Analyst Robert Hawkins at Stifel Nicolaus has released an update on AmSurg Corp. (NASDAQ: AMSG).
According to Stifel Nicolaus, the company’s earnings face significant headwinds this year. Stifel Nicolaus has lowered the estimates for the company after reviewing the items in the 10K.
The EPS for 2010 has been lowered from $1.84 to $1.78. Stifel Nicolaus also estimates a higher interest rate, and a drop of 50 basis points in margins.
Stifel Nicolaus continues to rate AmSurg Corp. as a Buy, with a price target of $25.